1
|
Zhou RF, Zhu ZN, Wang ZY, Zang JJ, Jia XD, Lyu J, Li LM, Wu F. [A case-control study on the association between a healthy lifestyle and obesity among adult twins in Shanghai]. Zhonghua Liu Xing Bing Xue Za Zhi 2023; 44:862-867. [PMID: 37380405 DOI: 10.3760/cma.j.cn112338-20221114-00970] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 06/30/2023]
Abstract
Objective: To investigate the associations between the numbers of healthy lifestyles and overweight/obesity and abdominal obesity in adult twins in Shanghai. Methods: Based on the Shanghai Twin Registry System Phase Ⅱ survey data in 2017-2018, a case-control study was conducted to analyze the association between healthy lifestyles and obesity and further adjusted for confounders by a co-twin control study. Results: A total of 7 864 adult twins (3 932 pairs) were included. In the co-twin case-control analysis for monozygotic twins, compared with participants with 0 to 2 healthy lifestyles, those with 3 and 4 to 5 healthy lifestyles had a 49% (OR=0.51, 95%CI: 0.28-0.93) and 70% (OR=0.30, 95%CI: 0.13-0.69) lower risk of overweight/obesity, respectively, and a 17% (OR=0.83, 95%CI: 0.44-1.57) and 66% (OR=0.34, 95%CI: 0.14-0.80) lower risk of abdominal obesity, respectively. For each additional healthy lifestyle, the risk of developing overweight/obesity was reduced by 41% (OR=0.59, 95%CI: 0.42-0.85), and the risk of developing abdominal obesity was reduced by 37% (OR=0.63, 95%CI: 0.44-0.90). Conclusion: An increasing number of healthy lifestyles was associated with a marked decreased risk for both overweight/obesity and abdominal obesity.
Collapse
Affiliation(s)
- R F Zhou
- School of Public Health, Fudan University, Shanghai 200032, China
| | - Z N Zhu
- Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China
| | - Z Y Wang
- Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China
| | - J J Zang
- Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China
| | - X D Jia
- Shanghai Chemical Industry Park Medical Center, Shanghai 201507, China
| | - J Lyu
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - L M Li
- Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - F Wu
- School of Public Health, Fudan University, Shanghai 200032, China
| |
Collapse
|
2
|
Zhou RF, He M, Yang B, Li X, Hu CJ. [Current practices in the harmonisation of autoantibodies test]. Zhonghua Nei Ke Za Zhi 2023; 62:356-362. [PMID: 37032129 DOI: 10.3760/cma.j.cn112138-20220422-00298] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/11/2023]
Abstract
Standardisation and harmonisation of the detection of autoantibodies is important for the clinical application of autoantibodies. However, achieving complete standardisation is difficult and involves several challenges due to the complexity and particularity of autoantibody detection. Harmonisation is feasible and valued, but it involves all aspects and processes of autoantibody detection. Based on the consensus and practice of the clinical application of autoantibody detection in recent years, we discuss harmonisation in this review.
Collapse
Affiliation(s)
- R F Zhou
- Department of Laboratory Medicine, Affiliated Wenling Hospital of Wenzhou Medical University, Taizhou 317500, China
| | - M He
- Department of Laboratory Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China
| | - B Yang
- Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu 610041, China
| | - X Li
- Department of Laboratory Medicine, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
| | - C J Hu
- Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China
| |
Collapse
|
3
|
Liu DF, Zhang XY, Zhou RF, Cai L, Yan DM, Lan LJ, He SH, Tang H. Glucose metabolism continuous deteriorating in male patients with human immunodeficiency virus accepted antiretroviral therapy for 156 weeks. World J Diabetes 2023; 14:299-312. [PMID: 37035225 PMCID: PMC10075030 DOI: 10.4239/wjd.v14.i3.299] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/01/2022] [Revised: 12/21/2022] [Accepted: 02/28/2023] [Indexed: 03/15/2023] Open
Abstract
BACKGROUND The dynamic characteristics of glucose metabolism and its risk factors in patients living with human immunodeficiency virus (PLWH) who accepted primary treatment with the efavirenz (EFV) plus lamivudine (3TC) plus tenofovir (TDF) (EFV + 3TC + TDF) regimen are unclear and warrant investigation.
AIM To study the long-term dynamic characteristics of glucose metabolism and its contributing factors in male PLWH who accepted primary treatment with the EFV + 3TC + TDF regimen for 156 wk.
METHODS This study was designed using a follow-up design. Sixty-one male treatment-naive PLWH, including 50 cases with normal glucose tolerance and 11 cases with prediabetes, were treated with the EFV + 3TC + TDF regimen for 156 wk. The glucose metabolism dynamic characteristics, the main risk factors and the differences among the three CD4+ count groups were analyzed.
RESULTS In treatment-naive male PLWH, regardless of whether glucose metabolism disorder was present at baseline, who accepted treatment with the EFV + 3TC + TDF regimen for 156 wk, a continuous increase in the fasting plasma glucose (FPG) level, the rate of impaired fasting glucose (IFG) and the glycosylated hemoglobin (HbA1c) level were found. These changes were not due to insulin resistance but rather to significantly reduced islet β cell function, according to the homeostasis model assessment of β cell function (HOMA-β). Moreover, the lower the baseline CD4+ T-cell count was, the higher the FPG level and the lower the HOMA-β value. Furthermore, the main risk factors for the FPG levels were the CD3+CD8+ cell count and viral load (VL), and the factors contributing to the HOMA-β values were the alanine aminotransferase level, VL and CD3+CD8+ cell count.
CONCLUSION These findings provide guidance to clinicians who are monitoring FPG levels closely and are concerned about IFG and decreased islet β cell function during antiretroviral therapy with the EFV + 3TC + TDF regimen for long-term application.
Collapse
Affiliation(s)
- Da-Feng Liu
- Department of Internal Medicine, Public Health and Clinical Center of Chengdu, Chengdu 610061, Sichuan Province, China
| | - Xin-Yi Zhang
- Department of Endocrinology and Metabolism, Sichuan University West China Hoapital, Chengdu 610041, Sichuan Province, China
| | - Rui-Feng Zhou
- Department of Infectious Disease, Public Health and Clinical Center of Chengdu, Chengdu 610061, Sichuan Province, China
| | - Lin Cai
- Department of Infectious Disease, Public Health and Clinical Center of Chengdu, Chengdu 610061, Sichuan Province, China
| | - Dong-Mei Yan
- Department of Infectious Disease, Public Health and Clinical Center of Chengdu, Chengdu 610061, Sichuan Province, China
| | - Li-Juan Lan
- Department of Internal Medicine, Public Health and Clinical Center of Chengdu, Chengdu 610061, Sichuan Province, China
| | - Sheng-Hua He
- Department of Infectious Disease, Public Health and Clinical Center of Chengdu, Chengdu 610061, Sichuan Province, China
| | - Hong Tang
- Center of Infectious Disease, Sichuan University West China Hoapital, Chengdu 610041, Sichuan Province, China
| |
Collapse
|
4
|
Yuan YH, Xu PP, Xu YY, Liu S, Shao XY, Zhang WJ, Gong L, Zhou M, Chen B, Zhou RF. [Analysis of the effects of low/intermediate dose of coagulation factor Ⅷ on 30 adult patients with severe hemophilia A in a single center]. Zhonghua Xue Ye Xue Za Zhi 2023; 44:38-42. [PMID: 36987721 PMCID: PMC10067379 DOI: 10.3760/cma.j.issn.0253-2727.2023.01.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 03/30/2023]
Abstract
Objective: To evaluate the clinical effects of low- and intermediate-dose factor Ⅷ (F Ⅷ) prophylaxis in Chinese adult patients with severe hemophilia A. Methods: Thirty adult patients with severe hemophilia A who received low- (n=20) /intermediate-dose (n=10) F Ⅷ prophylaxis at Nanjing Drum Tower Hospital affiliated with Nanjing University Medical College were included in the study. The annual bleeding rate (ABR), annual joint bleeding rate (AJBR), number of target joints, functional independence score of hemophilia (FISH), quality of life score, and health status score (SF-36) before and after preventive treatment were retrospectively analyzed and compared. Results: The median follow-up was 48 months. Compared with on-demand treatment, low- and intermediate-dose prophylaxis significantly reduced ABR, AJBR, and the number of target joints (P<0.05) ; the improvement in the intermediate-dose prophylaxis group was better than that in the low-dose prophylaxis group (P<0.05). Compared with on-demand treatment, the FISH score, quality of life score, and SF-36 score significantly improved in both groups (P<0.05), but there was no significant difference between the two groups (P>0.05) . Conclusion: In Chinese adults with severe hemophilia A, low- and intermediate-dose prophylaxis can significantly reduce bleeding frequency, delay the progression of joint lesions, and improve the quality of life of patients as compared with on-demand treatment. The improvement in clinical bleeding was better with intermediate-dose prophylaxis than low-dose prophylaxis.
Collapse
Affiliation(s)
- Y H Yuan
- Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - P P Xu
- Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - Y Y Xu
- Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - S Liu
- Department of Ultrasound, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - X Y Shao
- Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - W J Zhang
- Department of Ultrasound, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - L Gong
- Department of Ultrasound, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - M Zhou
- Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - B Chen
- Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - R F Zhou
- Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| |
Collapse
|
5
|
Xu YY, Ouyang J, Zhou M, Xu Y, Li P, Shao XY, Chen B, Zhou RF. [A case report of Kasabach-Merritt syndrome treated with vindesine sulfate]. Zhonghua Nei Ke Za Zhi 2019; 58:143-145. [PMID: 30704202 DOI: 10.3760/cma.j.issn.0578-1426.2019.02.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Affiliation(s)
- Y Y Xu
- Department of Hematology, Nanjing Drum Tower Hospital, Nanjing 210008, China
| | | | | | | | | | | | | | | |
Collapse
|
6
|
Chen QP, Zhou RF, Zhang YM, Yang L. [Efficacy of systemic glucocorticoids combined with inhaled steroid on children with acute laryngitis]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2018; 53:53-56. [PMID: 29365382 DOI: 10.3760/cma.j.issn.1673-0860.2018.01.012] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate the efficacy of systemic glucocorticoid (steroid) combined with high dose inhaled steroid in the treatment of children with acute laryngitis. Methods: A total of 78 children with acute laryngitis were randomly divided into study group(n=40) and control group(n=38) between November 2016 and April 2017. In addition to routine treatment of anti infection and symptomatic treatment, Dexamethasone injection(0.3-0.5 mg/kg, 1-3 d, according to the patient's condition) was provided to each group. In addition to the treatment mentioned above, the study group were assigned to receive 1.0 mg Budesonide suspension for inhalation, oxygen-driven atomizing inhalation, every/30 minutes, 2 times in a row, after that every 12 hours. The improvement of inspiratory dyspnea, hoarseness, barking cough and wheezing of both groups was evaluated at 30 min, 1 h, 2 h, 6 h, 12 h, 24 h and 72 h after treatment.Sigmaplot 11.5 software was used to analyze the data. Results: No significant difference was detected in terms of inspiratory dyspnea, hoarseness, barking cough or stridor score before treatment between the two groups(P>0.05). Compared with those before treatment, symptoms of inspiratory dyspnea, hoarseness, barking cough and stridor score of both groups improved markedly at 12 h and 24 h after treatment(P<0.05). While there was no significant difference regarding inspiratory dyspnea, hoarseness, barking cough or stridor score at each time point after treatment between the two groups(P>0.05). The effective rate was 92.50% and 92.11% in study group and control group, respectively, and no significant difference was noted (P>0.05). Conclusion: Compared with single systemic glucocorticoid, systemic glucocorticoids combined with inhaled steroid possessed similar efficacy in treating acute laryngitis and relieving laryngeal obstruction of children.
Collapse
Affiliation(s)
- Q P Chen
- Department of Paediatrics, Taizhou People's Hospital, Taizhou 225300, China
| | - R F Zhou
- Medical Technology Institute, Taizhou Polytechnic College, Taizhou 225300, China
| | - Y M Zhang
- Department of Paediatrics, Taizhou People's Hospital, Taizhou 225300, China
| | - L Yang
- Department of Paediatrics, Taizhou People's Hospital, Taizhou 225300, China
| |
Collapse
|
7
|
Gao B, Zhou RF, Ouyang J, Chen B, Xu Y, Li P. [Gene diagnosis of four patients with protein C deficiency]. Zhonghua Xue Ye Xue Za Zhi 2016; 37:966-970. [PMID: 27995882 PMCID: PMC7348508 DOI: 10.3760/cma.j.issn.0253-2727.2016.11.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
目的 探讨蛋白C缺陷症的分子发病机制。 方法 对4例蛋白C缺陷症患者进行常规诊断和基因分析。 结果 ①例1,女,40岁。临床诊断:左下肢深静脉血栓形成。蛋白C活性(PC∶C)48%,蛋白S活性(PS∶C)26.3%,抗凝血酶活性(AT∶C) 75.6%。基因检测结果:蛋白C基因(PROC)启动子C5156T杂合突变、2号外显子区域存在A6578T杂合突变。给予抗凝、溶栓、滤器植入等治疗,症状好转出院。②例2,女,32岁。临床诊断:双下肢深静脉血栓,双上、下肢缺血,双下肢皮肤软组织感染。PC∶C 27%,PS∶C 22.9%,AT∶C 86.7%。基因检测结果:PROC基因启动子C5156T杂合突变、A5045T杂合突变。给予抗凝、抗感染等治疗,因呼吸衰竭、感染性休克、DIC死亡。③例3,女,28岁。临床诊断:右髂静脉及股深静脉血栓。PC∶C 58%,PS∶C 57.3%,AT∶C 80.8%。基因检测结果:PROC启动子C4867T杂合突变,7号外显子12702-12704 AGA (Arg192)或12705-12707 AGA(Arg193)杂合缺失,9号外显子G15240A杂合突变。给予抗凝、溶栓、滤器植入等治疗,症状好转出院。④例4,男,30岁。临床诊断:左下肢深静脉血栓,双下肺动脉栓塞伴双下肺梗死。PC∶C 50%,PS∶C 75.0%,AT∶C 89.1%。基因检测结果:PROC启动子C4867T纯合突变、G4880A纯合突变和A5045T杂合突变,2号外显子T6589C杂合突变。给予抗凝、溶栓、滤器植入等相关治疗,症状好转出院。⑤多态性分析:PROC基因启动子C4867T杂合突变、G4880A纯合突变、C5156T杂合突变为PROC启动子多态性位点。 结论 PROC启动子多态性位点G4880A、C4867T、C5156T,错义突变A5045T、A6578T、G15240A,缺失突变AGA12702-12704del或12705-12707del可能与蛋白C缺陷症有关。PROC启动子错义突变A5045T、A6578T、G15240A,缺失突变AGA12702-12704del或12705-12706del是国际首次报告。
Collapse
Affiliation(s)
- B Gao
- Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
| | | | | | | | | | | |
Collapse
|
8
|
Abstract
Tissue factor (coagulation factor III) is a cell surface receptor for coagulation factor VII/VIIa; it was initially recognized as an initiator of the extrinsic coagulation pathway. Recently, the zebrafish tissue factor gene (TF) has been cloned. Paralogs encode coagulation factors IIIa and IIIb; both show remarkable sequence identity to the human and mouse coagulation factor III gene. It has been reported that TF could have additional properties that are essential for normal embryonic development, since knockout of the murine coagulation factor III gene resulted in 90% embryonic lethality. We examined the role of coagulation factor IIIb (f3b) during zebrafish embryonic development. Expression analysis revealed that endogenous f3b was chronologically expressed in the pectoral fins and in the vicinity of the pharynx. Knockout of f3b by injection of an f3b morpholino at the one-to-two cell stage caused distinctive morphological defects in embryos, including edema in the fourth brain ventricle at early embryonic stages and occasional bleeding at later stages. Furthermore, f3b morphants displayed abnormal vascular patterning. We conclude that f3b is required for brain vascular development and for development of part of the somatic vasculature during embryogenesis in the zebrafish.
Collapse
Affiliation(s)
- R F Zhou
- Key Laboratory of Molecular Medicine, Department of Biochemistry and Molecular Biology, Ministry of Education, Shanghai Medical College, Fudan University, Shanghai, PR China
| | | | | | | | | |
Collapse
|
9
|
Ma LM, Ding ZG, Gao TY, Zhou RF, Xu WY, Liu J. Discoloration of methylene blue and wastewater from a plant by a Fe/Cu bimetallic system. Chemosphere 2004; 55:1207-1212. [PMID: 15081761 DOI: 10.1016/j.chemosphere.2003.12.021] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/03/2003] [Revised: 12/12/2003] [Accepted: 12/28/2003] [Indexed: 05/24/2023]
Abstract
Using a Fe/Cu bimetallic system (Fe/Cu system), the discoloration of both methylene blue in aqueous solution and the colored wastewater from a plant was investigated under the anaerobic condition in batch or continuous reactors. Results show that the Fe/Cu system effectively removed the color with over 88% of color removal efficiency for both methylene blue solution and the wastewater from the plant in batch test. Color removal efficiencies increased rapidly with Fe/Cu dosage and reaction time, respectively, at initial time and slowly to stable values. Optimum pH was neutral range. In addition, in continuous test it also removed the color of the wastewater from the plant with 63% of discoloring efficiency under the condition of 2 h of hydraulic retention time and neutral range of pH (7.0-8.3). High discoloring efficiencies with low chemical oxygen demand removal efficiencies were found in all experiments. The reduction of chromophores in pollutants was the main mechanism of the discoloration in the Fe/Cu system.
Collapse
Affiliation(s)
- L M Ma
- The National Engineering Research Center for Urban Pollution Control, Tongji University, 1239 Siping Road, Shanghai 200092, PR China.
| | | | | | | | | | | |
Collapse
|
10
|
Zhou RF. [Therapeutic effect of local injection of corticosteroid hormone in the treatment of hemangioma in childhood and infancy]. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi 1993; 9:325-7, 396. [PMID: 8143197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Hemangioma is a common disease in infancy and childhood. From January, 1987 to January, 1992, the author had treated 11 out-patients of infants and children suffering from hemangioma with local injections of corticosteroid hormone and obtained an effective rate of 87.8% and cure rate of 51.2%. During the clinical observation, the author found that after injection, the hemangioma disappeared quickly without recurrence, infection, drug-induced side effects and other complications. It is considered that a mixture of corticosteroids is the first choice for local injection for the treatment of hemangioma in infancy and childhood. It is safe, effective and simple.
Collapse
Affiliation(s)
- R F Zhou
- Affiliated Subei Hospital of Yangzhou Medical College, China
| |
Collapse
|